BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7600619)

  • 1. Synthesis of 4-(phenylamino)quinoline-3-carboxamides as a novel class of gastric H+/K+-ATPase inhibitors.
    Uchida M; Otsubo K; Matsubara J; Ohtani T; Morita S; Yamasaki K
    Chem Pharm Bull (Tokyo); 1995 Apr; 43(4):693-8. PubMed ID: 7600619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and pharmacological characteristics of 3-butyryl-8-methoxy-4-[(2-thiophenyl)amino]quinoline, a new proton-pump inhibitor, in rabbit gastric microsomes and in rats.
    Kim KB; Chang MS; Chung YK; Sohn SK; Kim SG; Choi WS
    J Pharm Pharmacol; 1998 May; 50(5):521-9. PubMed ID: 9643446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological profile of 1-aryl-3-substituted pyrrolo[3,2-c]quinolines.
    Yum EK; Kang SK; Kim SS; Choi JK; Cheon HG
    Bioorg Med Chem Lett; 1999 Oct; 9(19):2819-22. PubMed ID: 10522698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
    Zhang Q; Huang N; Wang J; Luo H; He H; Ding M; Deng WQ; Zou K
    Fitoterapia; 2013 Sep; 89():210-7. PubMed ID: 23742858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antiulcer activity of 4-substituted 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinoli nes and related compounds.
    Uchida M; Chihiro M; Morita S; Yamashita H; Yamasaki K; Kanbe T; Yabuuchi Y; Nakagawa K
    Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1575-86. PubMed ID: 2170036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological properties of a newly synthesized H(+)/K(+) ATPase inhibitor, 1-(2-methyl-4-methoxyphenyl)-4-.
    Cheon HG; Lee SS; Lim H; Lee DH
    Eur J Pharmacol; 2001 Jan; 411(1-2):187-192. PubMed ID: 11137875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on proton pump inhibitors. II. Synthesis and antiulcer activity of 8-[(2-benzimidazolyl)sulfinylmethyl]-1,2,3,4-tetrahydroquinolines and related compounds.
    Uchida M; Chihiro M; Morita S; Kanbe T; Yamashita H; Yamasaki K; Yabuuchi Y; Nakagawa K
    Chem Pharm Bull (Tokyo); 1989 Aug; 37(8):2109-16. PubMed ID: 2557164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Soraprazan: setting new standards in inhibition of gastric acid secretion.
    Simon WA; Herrmann M; Klein T; Shin JM; Huber R; Senn-Bilfinger J; Postius S
    J Pharmacol Exp Ther; 2007 Jun; 321(3):866-74. PubMed ID: 17369284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Substituted methoxybenzyl-sulfonyl-1H-benzo[d]imidazoles evaluated as effective H
    Rajesh R; Manikandan A; Sivakumar A; Ramasubbu C; Nagaraju N
    Eur J Med Chem; 2017 Oct; 139():454-460. PubMed ID: 28818769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on antiulcer agents. I. Synthesis and pharmacological properties of ethyl 2-[(1H-benzimidazol-2-yl)sulfinylmethyl]-4-dimethylamino-5- pyrimidinecarboxylate, a new H+/K(+)-ATPase inhibitor possessing mucosal protective activity.
    Terashima K; Shimamura H; Kawase A; Tanaka Y; Uenishi K; Kimura I; Ishizuka Y; Sato M
    Chem Pharm Bull (Tokyo); 1995 Jan; 43(1):166-8. PubMed ID: 7895305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on proton pump inhibitors. I. Synthesis of 8-[(2-benzimidazolyl)sulfinyl]-5,6,7,8-tetrahydroquinolines and related compounds.
    Uchida M; Morita S; Chihiro M; Kanbe T; Yamasaki K; Yabuuchi Y; Nakagawa K
    Chem Pharm Bull (Tokyo); 1989 Jun; 37(6):1517-23. PubMed ID: 2550154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and drug efficacy validations of racemic-substituted benzimidazoles as antiulcer/antigastric secretion agents.
    Radhamanalan R; Alagumuthu M; Nagaraju N
    Future Med Chem; 2018 Aug; 10(15):1805-1820. PubMed ID: 30019937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ME-3407, a new antiulcer agent, inhibits acid secretion by interfering with redistribution of H(+)-K(+)-ATPase.
    Urushidani T; Muto Y; Nagao T; Yao X; Forte JG
    Am J Physiol; 1997 May; 272(5 Pt 1):G1122-34. PubMed ID: 9176222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A study comparing the antisecretory effect of TAK-438, a novel potassium-competitive acid blocker, with lansoprazole in animals.
    Hori Y; Matsukawa J; Takeuchi T; Nishida H; Kajino M; Inatomi N
    J Pharmacol Exp Ther; 2011 Jun; 337(3):797-804. PubMed ID: 21411494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery, synthesis, and structure-activity relations of 3,4-dihydro-1H-spiro(naphthalene-2,2'-piperidin)-1-ones as potassium-competitive acid blockers.
    Imaeda T; Ono K; Nakai K; Hori Y; Matsukawa J; Takagi T; Fujioka Y; Tarui N; Kondo M; Imanishi A; Inatomi N; Kajino M; Itoh F; Nishida H
    Bioorg Med Chem; 2017 Jul; 25(14):3719-3735. PubMed ID: 28522264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AHR-9294: a novel inhibitor of H,K-ATPase antagonizes gastric HCl secretion in vivo.
    Reenstra WW; Pinkus LM; Bailey J; Smith WL; Droppleman D; Sancilio LF; Forte JG
    J Pharmacol Exp Ther; 1992 May; 261(2):737-45. PubMed ID: 1315865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversible inhibitors of the gastric (H+/K+)-ATPase. 3. 3-substituted-4-(phenylamino)quinolines.
    Ife RJ; Brown TH; Keeling DJ; Leach CA; Meeson ML; Parsons ME; Reavill DR; Theobald CJ; Wiggall KJ
    J Med Chem; 1992 Sep; 35(18):3413-22. PubMed ID: 1326634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological reports about gastroprotective effects of methanolic extract from leaves of Solidago chilensis (Brazilian arnica) and its components quercitrin and afzelin in rodents.
    de Barros M; Mota da Silva L; Boeing T; Somensi LB; Cury BJ; de Moura Burci L; Santin JR; de Andrade SF; Monache FD; Cechinel-Filho V
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):403-17. PubMed ID: 26758066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological profile of novel acid pump antagonist 7-(4-fluorobenzyloxy)-2,3-dimethyl-1-{[(1S,2S)-2-methyl cyclopropyl]methyl}-1H-pyrrolo[2,3-d]pyridazine (CS-526).
    Ito K; Kinoshita K; Tomizawa A; Inaba F; Morikawa-Inomata Y; Makino M; Tabata K; Shibakawa N
    J Pharmacol Exp Ther; 2007 Oct; 323(1):308-17. PubMed ID: 17630360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The gastric H,K ATPase as a drug target: past, present, and future.
    Sachs G; Shin JM; Vagin O; Lambrecht N; Yakubov I; Munson K
    J Clin Gastroenterol; 2007 Jul; 41 Suppl 2(Suppl 2):S226-42. PubMed ID: 17575528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.